Valuation: Grand Pharmaceutical Group Limited

Market Cap 1.55TCr 197.74Cr 176.82Cr 163.59Cr 148.12Cr 277.22Cr 19TCr 281.76Cr 1.97TCr 778.67Cr 9.84TCr 742.15Cr 726.29Cr 31TCr P/E 2026 *
8.6x
P/E 2027 * 7.88x
Enterprise Value 1.55TCr 197.74Cr 176.82Cr 163.59Cr 148.12Cr 277.22Cr 19TCr 281.76Cr 1.97TCr 778.67Cr 9.84TCr 742.15Cr 726.29Cr 31TCr EV / Sales 2026 *
1.2x
EV / Sales 2027 * 1.1x
Free-Float
34.99%
Yield 2026 *
4.74%
Yield 2027 * 5.19%
1 day-0.56%
1 week-5.67%
Current month-10.65%
1 month-8.99%
3 months-14.47%
6 months-30.52%
Current year-43.89%
1 week 4.32
Extreme 4.325
4.73
1 month 4.32
Extreme 4.325
4.96
Current year 4.32
Extreme 4.325
8.18
1 year 4.32
Extreme 4.325
8.88
3 years 3.17
Extreme 3.17
10.2
5 years 3.17
Extreme 3.17
10.2
10 years 1.36
Extreme 1.36
10.2
Manager TitleAgeSince
Chief Executive Officer 36 01/06/2021
Corporate Secretary 57 01/09/2011
Director TitleAgeSince
Director/Board Member 63 21/03/2005
Director/Board Member 62 31/12/2018
Director/Board Member 66 12/05/2011
Date Insider Type Main position Quantity % Market Cap. Importance
07/09/26 Other

Chief Executive Officer

21,500 0.0006%
22/04/26 Other

Chairman

50,000 0.0014%
21/04/26 Other

Chief Executive Officer

58,500 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.56%-5.67%-46.61%+7.44% 198.93Cr
+0.45%+3.13%+54.96%+125.16% 1,13500Cr
+0.94%+4.93%+39.86%+78.72% 64TCr
+0.39%+1.44%+25.77%+97.48% 50TCr
+1.43%+4.31%+46.20%+67.12% 38TCr
-3.21%-2.10%+60.72%+33.22% 36TCr
-0.41%+2.64%+22.48%+49.82% 29TCr
+0.23%+3.66%+2.57%+23.69% 27TCr
+1.22%+4.63%+52.40%+64.85% 24TCr
+1.70%+3.67%+31.21%+102.15% 19TCr
Average +0.19%+2.22%+28.96%+64.97% 40.06TCr
Weighted average by Cap. +0.42%+2.84%+41.36%+83.57%

Financials

2026 *2027 *
Net sales 1.29TCr 164.99Cr 147.53Cr 136.49Cr 123.58Cr 231.3Cr 16TCr 235.09Cr 1.64TCr 649.7Cr 8.21TCr 619.22Cr 605.99Cr 26TCr 1.41TCr 179.75Cr 160.73Cr 148.71Cr 134.64Cr 252Cr 17TCr 256.13Cr 1.79TCr 707.85Cr 8.94TCr 674.65Cr 660.23Cr 28TCr
Net income 182.65Cr 23Cr 21Cr 19Cr 17Cr 33Cr 2.22TCr 33Cr 231.78Cr 92Cr 1.16TCr 87Cr 86Cr 3.67TCr 199.1Cr 25Cr 23Cr 21Cr 19Cr 36Cr 2.41TCr 36Cr 252.65Cr 100Cr 1.26TCr 95Cr 93Cr 4TCr
Net Debt - -
Projected Income Statement - Annual - Grand Pharmaceutical Group Limited
Logo Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
Employees
12,326
Date Price Change Volume
27/26/27 HK$4.405 -0.56% 2,42,000
26/26/26 HK$4.430 -0.56% 31,82,000
23/26/23 HK$4.455 +1.14% 18,09,000
22/26/22 HK$4.405 -3.72% 56,72,500
21/26/21 HK$4.575 -2.03% 22,35,500
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Grand Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.430HKD
Average target price
9.527HKD
Spread / Average Target
+115.05%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Grand Pharmaceutical Group Limited